Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 [WEBINAR] PCM: What is the Best Business Strategy for You? | Contract Pharma

What are you searching for?

Sign in
News Releases

[WEBINAR] PCM: What is the Best Business Strategy for You?

As a company producing Oral Solid Dose drug products, how can Pharmaceutical Continuous Manufacturing solve specific problems and help your business thrive?

Released By U.S. Pharmacopeia (USP)


Register Now!

Start Date & Time:
February 23, 2023 11:00 AM – 12:00 PM ET

Description:
As a company producing Oral Solid Dose drug products, how can Pharmaceutical Continuous Manufacturing (PCM) solve specific problems and help your business thrive? This webinar will guide you along the many advantages of PCM and how to achieve them. We will warn about barriers to adoption, and highlight business strategies specific to your organization.

Innovator Companies:
Improve the cost profile of an existing product or solve specific issues with a product. Developing a new product immediately in a continuous process can speed to market and reduce transfer and commercial manufacturing costs.

Generics, OTC, Nutraceutical Companies:
To deal with low margins, high competition, and a large and diverse portfolio, flexible batch size PCM can help cope with unpredictable volumes: strong process knowledge will minimize firefighting and product losses.

CDMOs:
Outsourcing plays a great role to bridge the period of uncertainty in bringing a product to market for innovators or lower the investment risk for companies ready to start with a Continuous Manufacturing process. CDMOs need a flexible solution that helps them serve a broad customer base. We will discuss how this can be done and the best moment to start.

Learning Objectives:
• Understand business case drivers, which choices to make, and when to implement PCM
• Develop a starting point to build a business case for using PCM for OSD drug product in various situations

Who should participate:
Drug manufacturing, pharmaceutical manufacturing, biologics organizations; Job function: quality assurance (QA), quality control (QC), operations managers, quality management, pharmaceutical quality directors, MHA, MPH. : Decision-makers for PCM – innovators, OTC, CDMOs; VP R & D; Manufacturing; Senior R & D; head of technology; CTO; COO; Technical services; technical operations; CFO; Finance

Speakers:
Lawrence De Belder, M.Sc., PCM Practice Lead, Pharmatech Associates – a USP company
Follow on LinkedIn

Register Now!

Request more information from U.S. Pharmacopeia (USP)

Request more information from U.S. Pharmacopeia (USP)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics